BeStock  
Stocks › Biotechnology › RAPP

Rapport Therapeutics RAPP

US equityMarket cap rank #2939Biotechnology
$23.16 −$0.43 (-1.82%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $23.16 0.00%
Open$23.23
Prev close$23.59
Day range$23.00 – $23.83
Volume437.7K
Market cap$1.37B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-8.2x
CheapRich

Above its usual level · 73rd percentile, 5-year average -11.0x

Price / book4.0x
CheapRich

Near the top of its 5-year range · 83rd percentile, 5-year average 1.1x

#4114 of 5331 stocks by PB (1 = cheapest)

Price / sales77.5x
CheapRich

Near the top of its 5-year range · 83rd percentile, 5-year average 19.9x

#4918 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-19x-12x-5x1xJun '24Aug '25Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$44.28
Price vs. fair value-47.7%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.96 – 1.10 83% (pricier than usual) #4114 of 5331 (1 = cheapest)
PE -8.25 -6.75 -10.97 73% (pricier than usual) –
PS 77.51 218,332.72 19.86 83% (pricier than usual) #4918 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on RAPP.

Sign in to join the discussion.

Scroll to Top